Dr. Funke explores
the changing genomic testing workflow and the trend towards genome wide testing, as well as current debates about using panels or exome testing.
Not exact matches
The report gave some examples of how
genomic testing clarified or
changed a patient's diagnosis, which in turn altered treatment and prognosis.
Also today, NHGRI and the National Cancer Institute (NCI), both part of the National Institutes of Health (NIH), announced that all three sequencing centers will devote a significant part of their efforts to The Cancer Genome Atlas (TCGA) Pilot Project, which is
testing the feasibility of a large - scale, systematic approach to identify important
genomic changes involved in cancer.
Friday, Oct. 9, 4:30 - 6:30 pm, Ballroom I Platform Session:
Changing landscape of
genomic testing Moderator (s): Lora Bean, Emory University; and Belinda Chong, VCGS, MCRI
The goal of
genomic tumor
testing is to identify
genomic changes in the cancer cells that are driving cancer growth for the...
Environmental Leader has a well written report explaining how EPA is
Changing the Way it
Tests Chemical Toxicity «Using recent advances in molecular biology,
genomics, and computational sciences, the new toxicity
testing methods will allow the EPA to screen thousands of environmental chemicals quickly for potentially harmful effects.»